Skip to main content
Zachary Bloomgarden, MD, Endocrinology, New York, NY

ZacharyT.BloomgardenMD

Endocrinology • New York, NY

Diabetes, Lipid Metabolism

Clinical Professor, Medicine - Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai

Join to view full profile

Dr. Bloomgarden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bloomgarden's full profile

Already have an account?

  • Office

    35 E 85th St
    New York, NY 10028
    Phone+1 212-879-5933
    Fax+1 212-861-7429

Summary

  • I am a clinician in private practice with an international reputation for writing and lecturing on diabetes, having authored more than 450 articles. I am Clinical Professor at Mount Sinai School of Medicine, and Editor of the Journal of Diabetes. I served on the Board of the American Association of Clinical Endocrinologists, the Journals Managing Subcommittee of the Endocrine Society, and the Editorial Board of Diabetes Care, and was principal investigator in numerous studies. In 2012, I was awarded the title of Master of the American College of Endocrinology. I have been listed for many years in the “Castle Connolly Guide: The Best Doctors New York Metro Area.”

    My interests span the overall field of diabetes. I have carefully followed the development of therapeutic approaches over the past two decades, and for many years wrote a renowned monthly commentary in Diabetes Care, entitled "Perspectives on the News," focusing on this and other aspects of clinical care. Currently, as the Editor of the Journal of Diabetes, I write frequent commentaries spanning various aspects of treatment. I am interested in the epidemiology of diabetes with particular focus on cardiovascular disease, and have paid particular attention to questions of cardiovascular safety and, even more important, to the potential for cardiovascular benefit of diabetes treatment. I have written on the inapplicability of current FDA recommendations for cardiovascular outcomes to the crucial questions we wish to examine in determining optimal therapeutic approaches. I also am a frequent commentator on novel treatment approaches including insulin treatment modalities, incretin-based treatments, and inhibitors of glucose transport aimed at increasing urinary glucose loss.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1977 - 1979
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1976 - 1977
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 1974 - 1975
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1975 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • Professor of Clinical Medicine Biocor Hospital de Doenças Cardiov, 1998
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Angiogenic gene therapy for improving islet graft vascularization.  
    Zhang N, Anthony K, Shinozaki K, Altomonte J, Bloomgarden Z, Dong H, Gene Therapy and Molecular Biology
  • Insulin-Resistant States and Cardiovascular Disease.  
    Bloomgarden, ZT, Practical Diabetology
  • Medical Prejudice.  
    Bloomgarden, ZT, Practical Diabetology
  • Join now to see all

Books/Book Chapters

  • Beyond HbA1c and fasting glucose in diabetes management. 
    Phillips, LS, Hooper PL, Blonde L, Bloomgarden Z, Boyle PJ, Drexler AJ, Fonseca VA, Ginsberg HN, Grunberger G, Halter JB, Kahn SE, Khan MA, Levy P, Sowers JRPostgraduate Institute for Medicine, Englewood CO
  • Self-Assessment Profile in Endocrinology and Metabolism. 
    Chapter: Complications of diabetes mellitus 
    Page 81 - 91Bloomgarden, ZTEditors: Palumbo PJ, Bower BF, Braithwaite SS, et al (AACE Self-Assessment Profile Committee).The American Association of Clinical Endocrinologists and The American College of Endocrinology, Jacksonville
  • Principles of Diabetes Mellitus. 
    Chapter: Prevention of microvascular complications of diabetes 
    Page 619 - 629Bloomgarden Z, Gouller, AEditors: Poretsky L.Kluwer Academic, Boston
  • Join now to see all

Abstracts/Posters

  • Can Variations in Blood Glucose be Predicted?
    Bloomgarden, ZT, An analysis of 1265 patient-days of home glucose monitoring, Diabetes
  • Brown "Serum Cholesterol in U.S. Population: Diabetics vs. Non-Diabetics, 1960-1980".
    Bloomgarden, ZT., and W.V, American Diabetes Association 23 International Research Symposium
  • Bloomgarden, Relative Risk of Insulin vs. Oral Agents: 14 Year Follow-up of Ischemic Heart Disease Mortality.
    Nagalingam, R., and ZT, Diabetes
  • Join now to see all

Other

Authored Content

  • 2019 ADA Scientific Sessions: Little Benefit of Vitamin D in Diabetes PreventionJune 2019
  • 2019 ADA Scientific Sessions: Little Benefit of Vitamin D in Diabetes PreventionJune 2019

Press Mentions

  • AACE/ACE Consensus Statement Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary
    AACE/ACE Consensus Statement Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive SummaryDecember 28th, 2020
  • Diabetes Drugs Looking for Broad Role in COVID-19
    Diabetes Drugs Looking for Broad Role in COVID-19August 24th, 2020
  • Researchers Say People with Prediabetes May Want to Take Vitamin D — Here’s Why
    Researchers Say People with Prediabetes May Want to Take Vitamin D — Here’s WhyJuly 22nd, 2020
  • Join now to see all

Committees

  • member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2021
  • member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
  • member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
  • member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
  • member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
  • member, American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan 2015

Professional Memberships

Other Languages

  • Chinese (Mandarin), French

Dr. Zachary Bloomgarden, Dr. Zachary Bloomgarden, MD, Dr. Z Bloomgarden, Dr. Zachary T. Bloomgarden